Login
$TRXA
$0.65 -$0.05 (7.14%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q3 FY2025
As of Mar 31, 2025
Q2 FY2025
As of Dec 31, 2024
Q1 FY2025
As of Oct 20, 2024
Q4 FY2024
As of Jun 30, 2024
Q3 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Dec 31, 2023
Q1 FY2024
As of Sep 30, 2023
Q4 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Mar 31, 2023
Q2 FY2023
As of Dec 31, 2022
Q1 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Mar 31, 2022
Q2 FY2022
As of Dec 31, 2021
Q1 FY2022
As of Sep 30, 2021
Q4 FY2021
As of Jun 30, 2021
CURRENT ASSETS:
Cash
Crypto currency held
Cash & cash equivalents
Crypto currency held
Accounts receivable, net
Prepaid consulting
Fair value of bitcoin held as investment
Prepaid expense
TOTAL CURRENT ASSETS
Plant and equipment, net
Prepaid consulting - noncurrent
Facility deposit
TOTAL NON-CURRENT ASSETS
Intangible assets, net
Prepaid consulting, noncurrent
Other assets
TOTAL NON CURRENT ASSETS
TOTAL ASSETS
CURRENT LIABILITIES:
Accounts payable and accrued expenses
Note payable
Advances payable - related parties
Due to related party
Deposit payable
Interest payable, unrelated party
Due to related party- accrued compensation
Due to related party- advances
Notes payable- third parties
Interest payable- third parties
Note payable, net of debt discount - unrelated parties
Note payable - unrelated parties
Accrued interest
Interest payable - unrelated parties
Notes payable - related parties
Interest payable - related parties
Derivative liability
Deposit payable
TOTAL CURRENT LIABILITIES
Non-current liabilities
Note payable - related party (noncurrent)
NON-CURRENT LIABILITIES:
Stock subscription payable (liability)
TOTAL NON-CURRENT LIABILITIES
TOTAL LIABILITIES
Commitments and contingencies (Note 10)
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, 0.0001 par value, authorized 350,000,000 shares and 30,149,940 and 25,067,479 issued and outstanding as of March 31, 2026, and June 30, 2025, respectively
Series A Preferred stock, 0.001 par value, authorized 10,000 shares and 2,475 and 0 issued and outstanding as of March 31, 2026, and June 30, 2025, respectively
Additional paid In capital
Shares to be issued
Stock subscription payable (equity)
Deferred Stock Compensation (Contra Equity)
Deferred Stock Compensation ( Contra Equity)
Stock subscription payable
Accumulated deficit
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support